These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 10727439)

  • 1. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.
    Accad M; Smith SJ; Newland DL; Sanan DA; King LE; Linton MF; Fazio S; Farese RV
    J Clin Invest; 2000 Mar; 105(6):711-9. PubMed ID: 10727439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipid-laden foam cell: an elusive target for therapeutic intervention.
    Brewer HB
    J Clin Invest; 2000 Mar; 105(6):703-5. PubMed ID: 10727436
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.
    Fazio S; Major AS; Swift LL; Gleaves LA; Accad M; Linton MF; Farese RV
    J Clin Invest; 2001 Jan; 107(2):163-71. PubMed ID: 11160132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.
    Wakabayashi T; Takahashi M; Yamamuro D; Karasawa T; Takei A; Takei S; Yamazaki H; Nagashima S; Ebihara K; Takahashi M; Ishibashi S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2576-2589. PubMed ID: 30354239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia.
    Yagyu H; Kitamine T; Osuga J; Tozawa R; Chen Z; Kaji Y; Oka T; Perrey S; Tamura Y; Ohashi K; Okazaki H; Yahagi N; Shionoiri F; Iizuka Y; Harada K; Shimano H; Yamashita H; Gotoda T; Yamada N; Ishibashi S
    J Biol Chem; 2000 Jul; 275(28):21324-30. PubMed ID: 10777503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.
    Aiello RJ; Brees D; Bourassa PA; Royer L; Lindsey S; Coskran T; Haghpassand M; Francone OL
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):630-7. PubMed ID: 11950702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.
    Su YR; Dove DE; Major AS; Hasty AH; Boone B; Linton MF; Fazio S
    Circulation; 2005 May; 111(18):2373-81. PubMed ID: 15851589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.
    Kusunoki J; Hansoty DK; Aragane K; Fallon JT; Badimon JJ; Fisher EA
    Circulation; 2001 May; 103(21):2604-9. PubMed ID: 11382731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.
    Bonthu S; Heistad DD; Chappell DA; Lamping KG; Faraci FM
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2333-40. PubMed ID: 9409199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of ACAT1 Attenuates Atherosclerosis Aggravated by Loss of NCEH1 in Bone Marrow-Derived Cells.
    Yamazaki H; Takahashi M; Wakabayashi T; Sakai K; Yamamuro D; Takei A; Takei S; Nagashima S; Yagyu H; Sekiya M; Ebihara K; Ishibashi S
    J Atheroscler Thromb; 2019 Mar; 26(3):246-259. PubMed ID: 30282838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACAT1 deletion in murine macrophages associated with cytotoxicity and decreased expression of collagen type 3A1.
    Rodriguez A; Ashen MD; Chen ES
    Biochem Biophys Res Commun; 2005 May; 331(1):61-8. PubMed ID: 15845358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
    Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
    Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages.
    Dove DE; Su YR; Zhang W; Jerome WG; Swift LL; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):128-34. PubMed ID: 15499044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACAT1 deficiency increases cholesterol synthesis in mouse peritoneal macrophages.
    Dove DE; Su YR; Swift LL; Linton MF; Fazio S
    Atherosclerosis; 2006 Jun; 186(2):267-74. PubMed ID: 16144700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid
    Melton EM; Li H; Benson J; Sohn P; Huang LH; Song BL; Li BL; Chang CCY; Chang TY
    J Biol Chem; 2019 Oct; 294(43):15836-15849. PubMed ID: 31495784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice.
    Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1961-7. PubMed ID: 10938018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis.
    Rudel LL; Lee RG; Cockman TL
    Curr Opin Lipidol; 2001 Apr; 12(2):121-7. PubMed ID: 11264983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.